v3.26.1
Balances and Transactions with Related Parties
3 Months Ended
Mar. 31, 2026
Balances and Transactions with Related Parties [Abstract]  
Balances and Transactions With Related Parties
16. Balances and Transactions with Related Parties

 

The principal related parties with which the Company had transactions during the years presented are as follows:

 

Name of Entity or Individual   Relationship with the Company
New Era Group Zhejiang New Energy Materials Co., Ltd.   Shareholder of Company’s subsidiary
Shenzhen Bak New Material Technology Co., Ltd   Note a
Zhengzhou BAK Battery Co., Ltd (“Zhenghzhou BAK”)   Note b, d
Shenzhen BAK Battery Co., Ltd (“SZ BAK”)   Former subsidiary and refer to Note c, d
Shenzhen BAK Power Battery Co., Ltd (“BAK SZ”)   Former subsidiary and refer to Note c, d
Zhejiang Shengyang Renewable Resources Technology Co., Ltd. (“Zhejiang Shengyang”)   Note f
Fuzhou BAK Battery Co., Ltd (“Fuzhou Bak”)   Note e, g
Zhengzhou BAK Electronics Co., Ltd   Note e, h
Zhengzhou BAK New Energy Vehicle Co., Ltd   Note i
Shenzhen BAK Medical Technology Co., Ltd (“SZ BAK Medical”)   Note e, j

 

(a) Ms. Xiuzhu Li, one of the major shareholders of CBAK effective from December 3, 2025, is the major shareholder of Shenzhen BAK New Material Technology Co., Ltd, holding 46.32% equity interest.

 

(b) Mr. Xiangqian Li, the Company’s former CEO, is a director of Zhengzhou BAK and Zhengzhou BAK is a wholly owned subsidiary of BAK SZ.

 

(c) Mr. Xiangqian Li, the Company’s former CEO, is a director of SZ BAK and BAK SZ. SZ BAK and BAK SZ were the former subsidiaries of the Company. SZ BAK has 29.14% equity interests in BAK SZ. Mr. Xiangqian Li is the major shareholder of SZ BAK, he owned 51% equity interest in SZ BAK.

 

(d) An immediate family member of Ms. Xiuzhu Li has major interests and is the director of these entities.

 

(e) An immediate family member of Ms. Xiuzhu Li has major interests in serval entities set forth in the above table.

 

(f) Hitrans has 26% equity interest in Zhejiang Shengyang (note 10).

 

(g) Zhengzhou BAK has 51% equity interest in Fuzhou BAK.

 

(h) BAK SZ has 100% equity interests in Zhengzhou BAK Electronics Co., Ltd.

 

(j) SZ BAK was the former shareholder of Zhengzhou BAK New Energy Vehicle Co., Ltd to April 10, 2023.
   
(j) SZ BAK Medical is a wholly owned subsidiary of SZ BAK.

Related party transactions

 

The Company entered into the following significant related party transactions:

 

   For the three months ended March 31, 
   2025   2026 
Purchase of batteries from Zhengzhou BAK  $4,132   $5,292,077 
Purchase (purchase return) of batteries from Fuzhou BAK   3,369    (152,143)
Purchase of materials from Zhejiang Shengyang   2,055,686    538,894 
Sub-contracting services provided by Fuzhou BAK   
-
    432,762 
Purchase of materials from SZ BAK Medical   
-
    310,813 
Sales of cathode raw materials to Zhengzhou BAK   1,150,068    8,139,436 
Sales of cathode raw materials to BAK SZ   4,620    2,172 
Sales of cathode raw materials to Zhengzhou BAK Electronics Co., Ltd   176,512    278,381 
Sales of cathode raw materials to Zhengzhou BAK in relation to non-operating agency-based service   2,168,931    
-
 
Sales of cathode raw materials to Zhengzhou BAK Electronics Co., Ltd in relation to non-operating agency-based service   125,680    
-
 
Sales of cathode raw materials to BAK SZ in relation to non-operating agency-based service   4,748    
-
 

 

Related party balances

 

Apart from the above, the Company recorded the following significant related party balances as of December 31, 2025 and March 31, 2026:

 

Receivables from former subsidiary

 

   December 31,
2025
   March 31,
2026
 
Receivables from BAK SZ  $4,389   $2,459 

 

Balance as of December 31, 2025 and March 31, 2026 represented trade receivable for sales of cathode raw materials to BAK SZ.

 

Other balances due from/ (to) related parties

 

   December 31,
2025
   March 31,
2026
 
Trade receivable, net – Zhengzhou BAK (i)  $4,836,152   $8,468,034 
Trade receivable, net – Zhengzhou BAK Electronics Co., Ltd. (i)  $237,446   $314,160 
Trade payable, net – Zhengzhou BAK (ii)  $4,453,603   $7,189,235 
Trade payable, net – Zhejiang Shengyang (iii)  $1,136,860   $823,876 
Trade payable, net - Shenzhen BAK New Material Technology Co., Ltd (iii)  $164,887   $167,367 
Trade payable, net – SZ BAK Medical (iii)  $428,572   $611,973 
Deposit paid for acquisition of long-term investments – BAK SZ (note 12)  $16,503,014   $16,751,291 
Dividend payable to non-controlling interest of Hitrans (note 15)  $1,271,109   $1,290,232 

 

(i) Representing trade receivable from sales of cathode raw materials.
   
(ii) Representing trade payables on purchase of batteries.

 

(iii) Representing trade payables on purchase of materials for manufacturing

Payables to a former subsidiary

 

Payables to a former subsidiary as of December 31, 2025 and March 31, 2026 consisted of the following:

 

   December 31,   March 31, 
   2025   2026 
Payables to BAK SZ  $407,506   $402,708 

 

Balance as of December 31, 2025 and March 31, 2026 consisted of payables for purchase of inventories.